Floatz logo

Lapine T-Lymphocyte Immune Globulin

Mixed Phenotype Acute Leukemia

Children's Oncology GroupPhase 3Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
35/ 100
Competitive Position
73/ 100

Competitive context

71 Active assets in the Mixed Phenotype Acute Leukemia cohort.

Asset / SponsorPhaseRating
Daunorubicin
St. Jude Children's Research Hospital
Phase 4BB
Cytosin-Arabinosid
Children's Oncology Group
Phase 4BB
ETOPOSIDE
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 3BB
DEXAMETHASONE
St. Jude Children's Research Hospital
Phase 4BB
METHOTREXATE
Children's Oncology Group
Phase 4BB

View all 50 →

Same molecule, other indications

Lapine T-Lymphocyte Immune Globulin is also rated in:

bone marrow failure syndromeDormant
CCC
Indicative ·
48 / 100
View asset →
congenital amegakaryocytic thrombocytopeniaDormant
CCC
Indicative ·
48 / 100
View asset →
Diamond-Blackfan anemiaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →